Form 4 for BVS Bioventus Inc.
Accepted 2024-06-24 00:00:00 ET · period of report 2024-06-20 · accession 0001578563-24-000318 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-24 | 2024-06-20 | BVS | Singleton Mark Leonard | SVP, CFO | M - OptEx | $0.00 | +31.0K | 94.1K | +49% | $0 |
| D | 2024-06-24 | 2024-06-20 | BVS | Singleton Mark Leonard | SVP, CFO | M - OptEx | $0.00 | -31.0K | 31.0K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-06-20 | M | A | 31,000 | $0.00 | 94,114 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2024-06-20 | M | D | 31,000 | $0.00 | 31,000 | D | — · — to — | 31,000 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. (F2) The RSUs shall vest 50% on the twelve-month anniversary of the date of grant, and the remaining 50% shall vest on the eighteenth-month anniversary of the date of grant, subject to the Reporting Person continuing in service through the applicable vesting date. |